American Society for Clinical Oncology Annual Meeting 2019
31 May - 4 June 2019 | McCormick Place, Chicago, IL, Booth #21124
Selected articles
Biology of Blood and Marrow Transplantation
Immuno-Oncology Technology
Lung Cancer
- Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer
- Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab